"Unit operating costs benefitted from significantly higher...

"Unit operating costs benefitted from significantly higher concentrate sold during the quarter, however this was mostly offset by unfavourable inventory movements resulting from the sale of higher cost inventory built up over the first half of the 2024 fiscal year. The unfavourable inventory movements were a reversal of the favourable inventory movements observed in the prior quarter."

So this tells me Q3 costs were higher than they should be due to inventory movement and Q2 should have been higher. So there has been cost improvement and the Q3 number is a little misleading.Costs are coming down due to higher production.

A question, is Unit Operating Cost (FOB) based on ‘Concentrate Produced’ 40,439 dmt or ‘Concentrate Sold’ 58,055 dmt? I assume, maybe wrongly, that it is ‘Concentrate Produced’ and this is what is meant by the ‘unfavourable inventory movements.’ Following on from this, not every extra production of 1 dmt equates to an equal increase in Unit Operating Cost, there are costs which will just relate to the quarter, not to the volume, hence there would be improvement in pricing if there was closer to 58,055 dmt produced as opposed to 40,439. There would be a cost per dmt improvement.Ie fixed production costs spread over more dmt production. Is my understanding correct?